Global gene expression in human myocardium—oligonucleotide microarray analysis of regional diversity and transcriptional regulation in heart failure

To obtain region- and disease-specific transcription profiles of human myocardial tissue, we explored mRNA expression from all four chambers of eight explanted failing [idiopathic dilated cardiomyopathy (DCM), n=5; ischemic cardiomyopathy (ICM), n=3], and five non-failing hearts using high-density oligonucleotide arrays (Affymetrix U95Av2). We performed pair-wise comparisons of gene expression in the categories (1) atria versus ventricles, (2) disease-regulated genes in atria and (3) disease-regulated genes in ventricles. In the 51 heart samples examined, 549 genes showed divergent distribution between atria and ventricles (272 genes with higher expression in atria, 277 genes with higher expression in ventricles). Two hundred and eighty-eight genes were differentially expressed in failing myocardium compared to non-failing hearts (19 genes regulated in atria and ventricles, 172 regulated in atria only, 97 genes regulated in ventricles only). For disease-regulated genes, down-regulation was 4.5-times more common than up-regulation. Functional classification according to Gene Ontology identified specific biological patterns for differentially expressed genes. Eleven genes were validated by RT-PCR showing a good correlation with the microarray data. Our goal was to determine a gene expression fingerprint of the heart, accounting for region- and disease-specific aspects. Recognizing common gene expression patterns in heart failure will significantly contribute to the understanding of heart failure and may eventually lead to the development of pathway-specific therapies.

[1]  M. Okabe,et al.  Signal transducer and activator of transcription 3 in the heart transduces not only a hypertrophic signal but a protective signal against doxorubicin-induced cardiomyopathy. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[2]  R. Carroll,et al.  Lipoprotein lipase activity in rat cardiomyocytes is stimulated by insulin and dexamethasone. , 1997, The Biochemical journal.

[3]  E. Marbán,et al.  Focal modification of electrical conduction in the heart by viral gene transfer , 2000, Nature Medicine.

[4]  Martin Vingron,et al.  Genome-Wide Array Analysis of Normal and Malformed Human Hearts , 2003, Circulation.

[5]  Salim Yusuf,et al.  Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure. , 1991, The New England journal of medicine.

[6]  Hans Lehrach,et al.  Expression profiling of human idiopathic dilated cardiomyopathy. , 2003, Cardiovascular research.

[7]  Ross Ihaka,et al.  Gentleman R: R: A language for data analysis and graphics , 1996 .

[8]  F. Tristani,et al.  A comparison of enalapril with hydralazine-isosorbide dinitrate in the treatment of chronic congestive heart failure. , 1991, The New England journal of medicine.

[9]  M. Dugas,et al.  Profound effect of normalization on detection of differentially expressed genes in oligonucleotide microarray data analysis , 2002, Genome Biology.

[10]  Guoying Liu,et al.  NetAffx: Affymetrix probesets and annotations , 2003, Nucleic Acids Res..

[11]  J. Mesirov,et al.  Molecular classification of cancer: class discovery and class prediction by gene expression monitoring. , 1999, Science.

[12]  M. Ashburner,et al.  Gene Ontology: tool for the unification of biology , 2000, Nature Genetics.

[13]  S Nattel,et al.  Differential distribution of inward rectifier potassium channel transcripts in human atrium versus ventricle. , 1998, Circulation.

[14]  K. Knobloch,et al.  Electrophysiological and antiarrhythmic effects of the novel IKur channel blockers, S9947 and S20951, on left vs. right pig atrium in vivo in comparison with the IKr blockers dofetilide, azimilide, d,l-sotalol and ibutilide , 2002, Naunyn-Schmiedeberg's Archives of Pharmacology.

[15]  E. Lakatta,et al.  Sex- and age-dependent human transcriptome variability: Implications for chronic heart failure , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[16]  S. Nattel,et al.  Antisense oligodeoxynucleotides directed against Kv1.5 mRNA specifically inhibit ultrarapid delayed rectifier K+ current in cultured adult human atrial myocytes. , 1997, Circulation research.

[17]  Paul D Allen,et al.  Global gene expression profiling of end-stage dilated cardiomyopathy using a human cardiovascular-based cDNA microarray. , 2002, The American journal of pathology.

[18]  Martin Vingron,et al.  Variance stabilization applied to microarray data calibration and to the quantification of differential expression , 2002, ISMB.

[19]  John Quackenbush,et al.  Genesis: cluster analysis of microarray data , 2002, Bioinform..

[20]  M. Le Cunff,et al.  Transcriptomal analysis of failing and nonfailing human hearts. , 2003, Physiological genomics.

[21]  L. Stanton,et al.  Altered patterns of gene expression in response to myocardial infarction. , 2000, Circulation research.

[22]  L. Hawthorn,et al.  Decreased SLIM1 Expression and Increased Gelsolin Expression in Failing Human Hearts Measured by High-Density Oligonucleotide Arrays , 2000, Circulation.

[23]  B. Strauss,et al.  Matrix remodeling in experimental and human heart failure: a possible regulatory role for TIMP-3. , 2003, American journal of physiology. Heart and circulatory physiology.

[24]  Vincent J. Carey,et al.  Visualization and Annotation of Genomic Experiments , 2003 .

[25]  E. Lankester A Treatise on Comparative Embryology , 1880, Nature.

[26]  J. Seidman,et al.  Chamber-specific cardiac expression of Tbx5 and heart defects in Holt-Oram syndrome. , 1999, Developmental biology.

[27]  George C Tseng,et al.  Microarray gene expression profiles in dilated and hypertrophic cardiomyopathic end-stage heart failure. , 2002, Physiological genomics.

[28]  G. Horgan,et al.  Relative expression software tool (REST©) for group-wise comparison and statistical analysis of relative expression results in real-time PCR , 2002 .

[29]  Y. Yazaki,et al.  Molecular cloning and characterization of human atrial and ventricular myosin alkali light chain cDNA clones. , 1988, Journal of Biological Chemistry.

[30]  E. Marbán Cardiac channelopathies , 2020, Nature.

[31]  M. Lazdunski,et al.  Molecular and functional properties of two-pore-domain potassium channels. , 2000, American journal of physiology. Renal physiology.

[32]  A. Bäumer,et al.  Gene expression of adrenomedullin in failing myocardium: comparison to atrial natriuretic peptide. , 2002, Journal of applied physiology.

[33]  G. Hasenfuss,et al.  Functional significance of angiotensin receptors in human myocardium. Significant differences between atrial and ventricular myocardium. , 1994, European heart journal.

[34]  R. Shohet,et al.  Transcriptional mapping and genomic analysis of the cardiac atria and ventricles. , 2002, Physiological genomics.

[35]  Jianbo Li,et al.  The gene expression fingerprint of human heart failure , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[36]  M. Weyand,et al.  Augmented Expression of Cardiotrophin-1 in Failing Human Hearts Is Accompanied by Diminished Glycoprotein 130 Receptor Protein Abundance , 2002, Circulation.

[37]  Rafael A. Irizarry,et al.  An R Package for Analyses of Affymetrix Oligonucleotide Arrays , 2003 .

[38]  M. Rajeevan,et al.  Copyright © American Society for Investigative Pathology and the Association for Molecular Pathology Validation of Array-Based Gene Expression Profiles by Real-Time (Kinetic) RT-PCR , 2022 .

[39]  William C Reinhold,et al.  MatchMiner: a tool for batch navigation among gene and gene product identifiers , 2003, Genome Biology.